DELAFIELD, Wis. (Stockpickr) -- Trading stocks that trigger major breakouts can lead to massive profits. Once a stock trends to a new high or takes out a prior overhead resistance point, then it's free to find new buyers and momentum players who can ultimately push the stock significantly higher.
>>5 Dividend Stocks That Want to Pay You More in 2014
One example of a successful breakout trade I flagged on May 30 at $14.30 a share was 3D printing player Voxeljet (VJET). I mentioned in that piece the stock had been consolidating and trending sideways for a few weeks, with shares moving between its 52-week low of $12.85 on the downside and right around $15 on the upside. This stock was starting to bounce higher off its 52-week low and was quickly moving within range of triggering a breakout trade above the upper-end of its recent sideways trading chart pattern.
Guess what happened? Shares Voxeljet triggered that breakout in mid-June with strong upside volume flows. This stock took out the upper-end of that previous range and it spiked back above its 50-day moving average. Shares of VJET have continued to soar higher since triggering that breakout, with the stock tagging an intraday high today of $19.75 a share. That represents a large gain of close to 40% for anyone who bought shares of VJET in anticipation of the breakout. As you can see, trading breakouts that triggering with strong volume and produce large profits in very short timeframes.
Best European Companies To Invest In Right Now: AptarGroup Inc. (ATR)
AptarGroup, Inc. engages in the design, development, manufacture, and sale of consumer product dispensing systems in North America, Europe, Asia, and South America. The company operates in three segments: Beauty + Home, Pharma, and Food + Beverage. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, and accessories to the personal care and household markets, as well as pumps and decorative components to the fragrance/cosmetic market; and fragrance/cosmetic and personal care fine mist spray pumps, personal care lotion pumps, and continuous spray aerosol valves. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments in pharmaceutical market. The Food + Beverage segment offers dispensing and non-dispensing closures, spray pumps, and aerosol valves to the food and beverage markets. AptarGroup, Inc. sells its products through sales force, independent representatives, and distributors. The c ompany was founded in 1992 and is headquartered in Crystal Lake, Illinois.
Advisors' Opinion:- [By Seth Jayson]
When judging a company's prospects, how quickly it turns cash outflows into cash inflows can be just as important as how much profit it's booking in the accounting fantasy world we call "earnings." This is one of the first metrics I check when I'm hunting for the market's best stocks. Today, we'll see how it applies to AptarGroup (NYSE: ATR ) .
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on AptarGroup (NYSE: ATR ) , whose recent revenue and earnings are plotted below.
Best Forestry Stocks To Own For 2015: Nu Skin Enterprises Inc.(NUS)
Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements worldwide. The company sells its personal care products under the Nu Skin brand; and nutritional supplements under the Pharmanex brand. Its personal care product line includes core systems, targeted treatments, total care, cosmetic, and Epoch, a product formulated with botanical ingredients. The company?s nutritional supplements product line comprises micronutrient supplements, targeted solution supplements, and weight management products. It also sells Vitameal, which are nutritious meal products for starving children or purchased for personal food storage. In addition, the company offers other products and services consisting of digital content storage, water purifiers, and other household products. It sells its products primarily through a network of independent distributors in north Asia, the Americas, Greater China, Europe, and the south Asia/Pacific. The c ompany also operates retail stores to sell its products in China. As of December 31, 2010, Nu Skin Enterprises operated 40 stores throughout China. The company was founded in 1984 and is headquartered in Provo, Utah.
Advisors' Opinion:- [By Ben Levisohn]
Shares of Herbalife have jumped 4.2% to $71.81 in after-hours trading after gaining 3.8% today. Herbalife, Nu Skin Enterprises (NUS) and Usana Health Sciences�(USNA) advanced today on reports that China was considering stricter regulation of multi-level sellers.
- [By Jonathan Berr]
Earlier this year, Chinese newspapers reported claims that Nu Skin (NUS), which provides personal care products, violated the country’s pyramid scheme losses. Although NUS stock was rallying today, shares still remain down more than 40% this year. NuSkin gets more than half of its revenue from the most populous country. Avon (AVP), which is fighting double-digit declines in representatives, is off about 15%. Tupperware is off similarly.
Best Forestry Stocks To Own For 2015: ANI Pharmaceuticals Inc (ANIP)
ANI Pharmaceuticals, Inc., incorporated on April 11, 2001, is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. In two facilities with combined manufacturing, packaging and laboratory capacity totaling 173, 00 square feet, the Company manufactures oral solid dose products, as well as liquids and topicals, including narcotics. Its other products include The Food and Drug Administration (FDA) approved testosterone gel, which is licensed to Teva Pharmaceuticals USA. In December 2013, the Company acquired 31 generic drug products from Teva Pharmaceuticals, which includes 20 solid-oral immediate release products, four extended release products and seven liquid products.
The Company performs contract manufacturing for other pharmaceutical companies. It has launched three products and has 11 products in development. The Company�� targeted areas of product development include narcotics, anti-cancers and hormones (potent compounds), and extended release niche generic product opportunities.
Advisors' Opinion:- [By Ben Levisohn]
ANI Pharmaceuticals (ANIP) has climbed 8.9% to $18.80 after it said it would buy 31 generic drugs from Teva Pharmaceuticals (TEVA). Teva’s shares are little changed in pre-open trading.
Best Forestry Stocks To Own For 2015: St. Jude Medical Inc.(STJ)
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantable cardioverter defibrillator systems to provide therapy to patients suffering from lethal heart conditions, such as sudden cardiac arrest; cardiac resynchronization therapy devices to treat heart failure patients; pacemakers to help people whose hearts beat too slowly or who suffer from other cardiac arrhythmias; and leads, which connect devices to the heart and carry the electrical impulses to the heart and information from the heart to the device. The Cardiovascular segment offers mechanical and tissue replacement heart valves, as well as heart valve repair products. It also pr ovides disposable interventional devices, including vascular closure devices, compression assist devices, percutaneous catheter introducers, diagnostic guidewires, and temporary bipolar pacing catheters, as well as diagnostic coronary imaging technology. The Atrial Fibrillation segment offers a system of products for access, diagnosis, visualization, and ablation that assist physicians in diagnosing and treating various irregular heart rhythms used in the electrophysiology lab and cardiac surgery. It provides electrophysiology introducers and catheters, cardiac mapping, navigation and recording systems, and ablation systems. The Neuromodulation segment offers a range of neurostimulation systems, such as rechargeable implantable pulse generators, primary cell implantable pulse generators, and radio frequency powered systems. St. Jude Medical markets its products through a direct sales force and independent distributors. The company was founded in 1976 and is headquartered in St. Paul, Minnesota.
Advisors' Opinion:- [By Ben Levisohn]
Stocks couldn’t fly high enough to get over�yesterday’s record high*, as shares of�McDonald’s�(MCD) and Allergan (AGN) and Valeant Pharmaceuticals (VRX) dropped, while St. Jude Medical (STJ) and Stryker (SYK) have gained.
- [By Dan Carroll]
It's safe to say medical-device maker St. Jude Medical (NYSE: STJ ) has had a big year. This stock's jumped more than 50% year to date as part of health care's rise in 2013. However, as shares have risen, St. Jude's sales and earnings haven't taken the same path higher.
Best Forestry Stocks To Own For 2015: Heico Corporation (HEI)
HEICO Corporation, through its subsidiaries, designs, manufactures, and sells aerospace, defense, and electronic related products and services in the United States and internationally. The company�s Flight Support Group segment provides jet engine and aircraft component replacement parts; thermal insulation blankets and parts; and specialty components for aerospace and industrial original equipment manufacturers, and the United States government. This segment also distributes hydraulic, pneumatic, mechanical, and electro-mechanical components for the commercial, regional, and general aviation markets; and offers repair and overhaul services for jet engine and aircraft component parts, avionics, instruments, composites, and flight surfaces of commercial airlines, as well as for avionics and navigation systems, subcomponents, and other instruments utilized on military aircrafts. Its Electronic Technologies Group segment provides a range of electronic, microwave, and electro -optical products, including infrared simulation and test equipment, laser rangefinder receivers, electrical and back-up power supplies, power conversion products, underwater locator beacons, electromagnetic and radio frequency interference shielding, capacitor charging power supplies, amplifiers, traveling wave tube amplifiers, photo detectors, amplifier modules, and microwave power modules. This segment also offers flash lamp and laser diode drivers, arc lamp power supplies, cable assemblies, high voltage power supplies, high voltage interconnection devices and wires, high voltage energy generators, and high frequency power delivery systems. Its products link devices, such as telemetry receivers, digital cameras, high resolution scanners, simulation systems, and test systems to computer for the U.S. and foreign military agencies, prime defense contractors, and commercial and defense satellite and spacecraft manufacturers. The company was founded in 1949 and is headquartere d in Hollywood, Florida.
Advisors' Opinion:- [By Nickey Friedman]
HEICO Corporation (NYSE: HEI ) reported its fiscal third quarter on Tuesday. Results were in-line with the average analyst estimate for adjusted EPS of $0.44 but came in a tad light on the revenue side with $291 million versus an expectation of $296 million.
- [By Rich Smith]
Hollywood, Fla.-based HEICO (NYSE: HEI ) is adding heft to its Flight Support Group.
On Monday, the niche aerospace and defense company announced that it has entered into a definitive agreement to buy Reinhold Industries from private equity firm The Jordan Company in a deal slated to close within the next 45 days.
Best Forestry Stocks To Own For 2015: Ocera Therapeutics Inc (OCRX)
Ocera Therapeutics, Inc., formerly Tranzyme, Inc., incorporated on January 12, 1998, is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing mechanism-based therapeutics for the treatment of upper gastrointestinal (GI) motility disorders. The Company is developing TZP-102, an oral ghrelin agonist for treating the symptoms associated with chronic upper GI motility disorders. Enrollment is complete in a multinational Phase-IIb trial evaluating TZP-102 given once daily in diabetic patients with gastroparesis. The Company has initiated a second Phase-IIb trial (DIGEST) evaluating TZP-102 given prior to meals in diabetic patients with gastroparesis. On July 15, 2013, Ocera Therapeutics, Inc. merged with the Company.
Ulimorelin (Intravenous Ghrelin Agonist)
Ulimorelin is an intravenous ghrelin agonist in Phase III clinical development for the acceleration of postoperative GI recovery. Ulimorelin is designed to accelerate the return of normal GI function in patients suffering from acute GI disorders. In addition to the ongoing trials, the Company has completed multiple trials of ulimorelin.
TZP-102 (Oral Ghrelin Agonist)
TZP-102 is an orally-administered ghrelin agonist, which it is developing for diabetic gastroparesis, an upper GI motility disorder. Gastroparesis is a debilitating, chronic condition characterized by slow or delayed gastric emptying and gastric retention that can be caused by any disease that induces neuromuscular dysfunction of the GI tract, notably diabetes.
Advisors' Opinion:- [By Jon C. Ogg]
Ocera Therapeutics Inc. (NASDAQ: OCRX) was started as Buy with a $19.00 price target at Stifel Nicolaus. This represents 62% upside to the $11.70 closing price. This positive call is based on a best-in-class mechanism action of its lead product candidate against hepatic encephalopathy in patients with acute and chronic liver disease.
- [By Monica Gerson]
Ocera Therapeutics (NASDAQ: OCRX) plummeted 16.01% to $13.80. Ocera Therapeutics shares have jumped 158.33% over the past 52 weeks, while the S&P 500 index has gained 23.35% in the same period.
No comments:
Post a Comment